BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3560091)

  • 1. Hepatitis B virus infection and liver function in patients with systemic lupus erythematosus.
    Bonafede RP; van Staden M; Klemp P
    J Rheumatol; 1986 Dec; 13(6):1050-2. PubMed ID: 3560091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus infection in patients with systemic lupus erythematosus.
    Chng HH; Fock KM; Chew CN; Guan R; Feng PH; Boey ML; Chee EN; Chua KL
    Singapore Med J; 1993 Aug; 34(4):325-6. PubMed ID: 8266204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalance of antibodies against hepatitis C and B viruses in patients with systemic lupus erythematosus].
    Mercado U; Avendaño-Reyes M; Araiza-Casillas R; Díaz-Molina R
    Rev Gastroenterol Mex; 2005; 70(4):399-401. PubMed ID: 17058978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C; Koç H; Karayalcin S; Akyol G; Gürman G; Ilhan O; Akan H; Ozcan M; Arslan O; Konuk N; Uysal A; Beksaç M
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy.
    Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC
    Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?
    Rodríguez-Torres M; Gonzalez-Garcia J; Bräu N; Solá R; Moreno S; Rockstroh J; Smaill F; Mendes-Correa MC; DePamphilis J; Torriani FJ;
    J Med Virol; 2007 Jun; 79(6):694-700. PubMed ID: 17457912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus infection in systemic lupus erythematosus: a case-control study.
    Perlemuter G; Cacoub P; Sbaï A; Hausfater P; Thibault V; Le TH; Wechsler B; Buffet C; Piette JC
    J Rheumatol; 2003 Jul; 30(7):1473-8. PubMed ID: 12858443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexistence of hepatitis B surface antigen (HBsAg) and heterologous subtype-specific antibodies to HBsAg among patients with chronic hepatitis B virus infection.
    Zhang JM; Xu Y; Wang XY; Yin YK; Wu XH; Weng XH; Lu M
    Clin Infect Dis; 2007 May; 44(9):1161-9. PubMed ID: 17407033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethnic differences in the incidence of postnecrotic cirrhosis in Israel: correlation with hepatitis B virus serological markers.
    Enat R; Ben-Porath E; Joffe B; Baruch J; Lichtig C
    Am J Gastroenterol; 1983 Oct; 78(10):656-60. PubMed ID: 6624742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus.
    Ramos-Casals M; Font J; García-Carrasco M; Cervera R; Jiménez S; Trejo O; de la Red G; Sánchez-Tapias JM; Ingelmo M
    Arthritis Rheum; 2000 Dec; 43(12):2801-6. PubMed ID: 11145039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M; Gómez MD; Berenguer M; Córdoba J; Rayón JM; Pastor M; García-Herola A; Nicolás D; Carrasco D; Orbis JF; Mir J; Berenguer J
    Liver Transpl; 2001 Jan; 7(1):51-8. PubMed ID: 11150423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus infection after renal transplantation in the presence of antibody to hepatitis B surface antigen immunity.
    Kim KH; Ahn SH; Chung HY; Paik YH; Lee KS; Kim YS; Chon CY; Moon YM; Han KH
    J Gastroenterol Hepatol; 2004 Aug; 19(8):847-53. PubMed ID: 15242485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there a pathogenetic role of hepatitis B virus in lupus nephritis?
    Lai KN; Lai FM; Lo S; Leung A
    Arch Pathol Lab Med; 1987 Feb; 111(2):185-8. PubMed ID: 3813833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study on the clinical and virological characteristics among patients with single occult hepatitis B virus (HBV), single occult hepatitis C virus (HCV) and occult HBV and HCV dual infection.
    Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Bartolomé J; Pardo M; Carreño V
    J Med Virol; 2007 Mar; 79(3):236-41. PubMed ID: 17245725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases.
    Georgiadou SP; Zachou K; Rigopoulou E; Liaskos C; Mina P; Gerovasilis F; Makri E; Dalekos GN
    J Viral Hepat; 2004 Jul; 11(4):358-65. PubMed ID: 15230859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
    Momosaki S; Nakashima Y; Kojiro M; Tabor E
    J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
    Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.
    Yu AS; Vierling JM; Colquhoun SD; Arnaout WS; Chan CK; Khanafshar E; Geller SA; Nichols WS; Fong TL
    Liver Transpl; 2001 Jun; 7(6):513-7. PubMed ID: 11443579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.